Patients’ clinical symptoms alleviated, IgG4‐RD RI and PGA decreased, as well as reduction of laboratory parameters including serum IgG, IgA, IgM, IgG4, IgE and ESR. Here, CD40LG is linked to immunoglobulin G4-related sclerosing disease.